Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chronic Pain × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 16 Breast Neoplasms 15 Pain 7 Agnosia 6 Prostatic Neoplasms 5 Lung Neoplasms 5 Neoplasms 4 Stomach Neoplasms 3 Colonic Neoplasms 3 Supratentorial Neoplasms 2 Postoperative Complications 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Kidney Neoplasms 1 Intraoperative Complications 1 Head and Neck Neoplasms 1 Goiter 1 Ganglion Cysts 1 Feeding and Eating Disorders 1 Emergence Delirium 1

Interventions

Morphine 7 Ketamine 4 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Surveys and Questionnaires 2 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Bupivacaine 2 Acetaminophen 2 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1 Telemedicine 1 Tea 1 Tapentadol 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02408393 2019-07-10

MIRs03

Institut Curie

Phase 3 Completed

Breast Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡